Answers are grounded in this paper and cite their sources.
The modified iron porphyrins with weak ligand (PF6–, BF4–) were prepared by a gentle and cheap approach. The catalytic systems with modified iron porphyrins and 1-butyl-3-methylimidazolium hexafluorophosphate ([Bmim]PF6) were used in the catalytic oxidative removal of sulfur compounds from model oil under mild conditions. The effect of anionic axial ligand on catalytic oxdative desulfurization performance was investigated. Iron porphyrins with weak ligand exhibited higher desulfurization performance, and the catalytic ability of catalysts was FeIIITPP(PF6) > FeIIITPP(BF4) > FeIIITPPCl. A dual active model mechanism was proposed to illustrate this phenomenon of oxidative process. The system of FeIIITPP(PF6) and [Bmim]PF6 could be recycled for 6 times without evident decrease of desulfurization efficiency.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: